Tepha, Inc.

Tepha, Inc. is a medical technology company based in Lexington, Massachusetts, founded in 1998. The company specializes in developing and manufacturing proprietary resorbable polymer technology using poly-4-hydroxybutyric acid (P4HB). This polymer platform supports soft tissue repair, reconstruction, and regeneration by providing temporary support that promotes tissue ingrowth and is gradually absorbed by the body. Tepha's core products include surgical mesh and suture products made from its P4HB polymer, which are utilized in various medical fields such as hernia repair, orthopedic soft tissue repair, general wound repair, and plastic and reconstructive surgery. The company has achieved significant regulatory clearances, including 23 FDA 510(k) approvals and 5 CE Mark clearances, and its products have been used in over 2 million surgical procedures worldwide. In 2021, Tepha was acquired by Becton, Dickinson and Company (BD), enhancing BD’s capabilities in surgical mesh and soft tissue repair.

• Employees 13
• Founded 1998
• Annual Revenue $5500000
• Total Funding $29942849